COPD in the elderly patient.

The elderly are especially prone to the adverse health effects of chronic obstructive pulmonary disease (COPD), which is a common disorder in that population. While the prevalence and morbidity of COPD in the elderly are high, it is often undiagnosed and thus undertreated. The diagnosis of COPD is primarily based on the physiological documentation of airflow limitation using spirometry. However, several controversies exist as to the range of predicted normal values for these measurements in the elderly population, and the clinical presentation of COPD in the elderly may be complicated by the presence of several comorbidities. Many non-pharmacological and pharmacological interventions are available for managing COPD. However, management of COPD in the elderly population may be challenged by the "polypharmacy" of medications that these patients often take, which can interfere with compliance with therapy. Additionally, the elderly often suffer from physical or cognitive disabilities that can prevent compliance with prescribed medications. Lastly, adverse effects from medications prescribed for treatment of COPD may be more pervasive in elderly patients.

[1]  D. Mannino,et al.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE OLDER ADULT: WHAT BEST DEFINES ABNORMAL LUNG FUNCTION? , 2006 .

[2]  H. Dastani,et al.  The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. , 2008, Respiratory medicine.

[3]  F. Harrell,et al.  Dying with Lung Cancer or Chronic Obstructive Pulmonary Disease: Insights from SUPPORT , 2000, Journal of the American Geriatrics Society.

[4]  A. Crockett,et al.  The FEV1/FEV6 ratio is a good substitute for the FEV1/FVC ratio in the elderly. , 2006, Primary care respiratory journal : journal of the General Practice Airways Group.

[5]  Joseph Menzin,et al.  Assessment of the Economic Burden of COPD in the U.S.: A Review and Synthesis of the Literature , 2006, COPD.

[6]  Y. Kurokawa,et al.  [Lung volume reduction surgery for chronic pulmonary emphysema in elderly patients]. , 2005, Kyobu geka. The Japanese journal of thoracic surgery.

[7]  A. Vallejo Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged , 2006, Immunologic research.

[8]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[9]  K. Wood,et al.  What Defines Abnormal Lung Function in Older Adults with Chronic Obstructive Pulmonary Disease? , 2008, Drugs & aging.

[10]  M. Fiore AHCPR smoking cessation guideline: a fundamental review. , 1997, Tobacco control.

[11]  K. Sullivan,et al.  Deciding about mechanical ventilation in end-stage chronic obstructive pulmonary disease: how respirologists perceive their role. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[12]  J. Heffner,et al.  Outcomes of advance directive education of pulmonary rehabilitation patients. , 1997, American journal of respiratory and critical care medicine.

[13]  D. Mahler,et al.  The aging lung. , 1986, Clinics in geriatric medicine.

[14]  Carolyn E Behrendt,et al.  Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. , 2005, Chest.

[15]  M. Svartengren,et al.  Long-term clearance from small airways decreases with age , 2005, European Respiratory Journal.

[16]  D. Patrick,et al.  Patient-physician communication about end-of-life care for patients with severe COPD , 2004, European Respiratory Journal.

[17]  J. Maurer Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study , 2010 .

[18]  P. Barberger‐Gateau,et al.  Expiratory flow limitation and obstruction in the elderly , 2005, European Respiratory Journal.

[19]  D. Patrick,et al.  Association of depression and life-sustaining treatment preferences in patients with COPD. , 2005, Chest.

[20]  J. Curtis,et al.  Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. , 2006, Archives of internal medicine.

[21]  T. Fujinaga,et al.  Importance of a comprehensive geriatric assessment in prediction of complications following thoracic surgery in elderly patients. , 2005, Chest.

[22]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[23]  D. Cook,et al.  Noninvasive positive pressure ventilation in critical and palliative care settings: Understanding the goals of therapy* , 2007, Critical care medicine.

[24]  S. Willsie A Prospective Clinical Study of Theophylline Safety in 3810 Elderly With Asthma or COPD , 2006 .

[25]  Y. Tohda,et al.  Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. , 2009, Respiratory medicine.

[26]  J. Hansen-Flaschen Chronic obstructive pulmonary disease: the last year of life. , 2004, Respiratory care.

[27]  William M Vollmer,et al.  Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? , 2006, Thorax.

[28]  T. Murphy,et al.  Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient. , 2002, Drugs & aging.

[29]  L. F. Black,et al.  Maximal respiratory pressures: normal values and relationship to age and sex. , 2015 .

[30]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[31]  D. Mannino,et al.  Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.

[32]  N. Pride Ageing and changes in lung mechanics , 2005, European Respiratory Journal.

[33]  F. Rengo,et al.  Use of Antibiotics in Elderly Patients with Exacerbated COPD: The OLD‐Chronic Obstructive Pulmonary Disease Study , 2006, Journal of the American Geriatrics Society.

[34]  J. Carline,et al.  Patients' perspectives on physician skill in end-of-life care: differences between patients with COPD, cancer, and AIDS. , 2002, Chest.

[35]  Jiachun Lu,et al.  COPD in Chinese nonsmokers , 2009, European Respiratory Journal.

[36]  J. Vestbo,et al.  COPD: the dangerous underestimate of 15% , 2006, The Lancet.

[37]  A. Buist,et al.  Reference values for arterial blood gases in the elderly. , 2004, Chest.

[38]  D. R. Jones Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial , 2007 .

[39]  William M Vollmer,et al.  Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. , 2005, Respiratory medicine.

[40]  D. Mannino COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. , 2002, Chest.

[41]  A. Sheikh,et al.  Illness trajectories and palliative care , 2005, BMJ : British Medical Journal.

[42]  M. Cazzola,et al.  The use of bronchodilators in the treatment of airway obstruction in elderly patients. , 2006, Pulmonary pharmacology & therapeutics.

[43]  H. Melbye,et al.  Lung function testing in the elderly - Can we still use FEV1/FVC < 70% as a criterion of COPD? , 2007 .

[44]  P. Ind,et al.  Inhaled therapy in elderly COPD patients; time for re-evaluation? , 2007, Age and ageing.

[45]  P. Barnes Future treatments for chronic obstructive pulmonary disease and its comorbidities. , 2008, Proceedings of the American Thoracic Society.

[46]  Gulshan Sharma,et al.  The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. , 2009, Proceedings of the American Thoracic Society.

[47]  A. Buist,et al.  Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers , 2002, European Respiratory Journal.

[48]  A. Agustí Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). , 2007, Proceedings of the American Thoracic Society.

[49]  S. Saryal,et al.  Differences between asthma and COPD in the elderly. , 2006, Journal of investigational allergology & clinical immunology.

[50]  P. Barnes,et al.  COPD as a disease of accelerated lung aging(a). , 2009, Revista portuguesa de pneumologia.

[51]  Alvar Agusti,et al.  Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.